等待开盘 06-26 09:30:00 美东时间
-0.015
-0.08%
Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it has entered
06-16 21:01
Simulations Plus announces an Nvidia deal to accelerate AI drug modeling, but weak growth and momentum metrics raise concerns about the long-term outlook.
05-06 23:50
Certara stock rises after $135 million divestiture to Veristat as analysts weigh MIDD focus and improving biopharma demand.
04-23 03:23
Companies Reporting Before The Bell • Acuity (NYSE:AYI) is projected to report ...
01-08 19:11
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-12-18 21:02
BTIG analyst David Larsen downgrades Simulations Plus (NASDAQ:SLP) from Buy to Neutral.
2025-12-18 20:16
Simulations Plus stock rises after beating earnings and reaffirming 2026 guidance as analysts highlight improving demand and long-term growth potential.
2025-12-03 01:52
Companies Reporting Before The Bell • Hafnia (NYSE:HAFN) is expected to report ...
2025-12-01 19:11
Simulations Plus (NASDAQ:SLP) will release its quarterly earnings report on Mon...
2025-11-28 22:01
登录新浪财经APP 搜索【信披】查看更多考评等级 《科创板日报》8月20日讯 今日科创板早报主要内容有:上海:支持电子信息、汽车、装备等重点行...
2025-08-20 08:15